X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (38) 38
humans (33) 33
oncology (27) 27
hematology (19) 19
female (18) 18
male (18) 18
aged (17) 17
aged, 80 and over (15) 15
cancer (12) 12
middle aged (11) 11
adult (10) 10
chemotherapy (10) 10
hematology, oncology and palliative medicine (9) 9
myelodysplastic syndromes (9) 9
treatment outcome (9) 9
prognosis (8) 8
acute myeloid-leukemia (7) 7
azacitidine (6) 6
leukemia (6) 6
therapy (6) 6
abridged index medicus (5) 5
article (5) 5
decitabine (5) 5
hypomethylating agents (5) 5
myelodysplastic syndromes - drug therapy (5) 5
retrospective studies (5) 5
risk assessment (5) 5
survival (5) 5
united states (5) 5
antimetabolites, antineoplastic - therapeutic use (4) 4
azacitidine - therapeutic use (4) 4
bone marrow - pathology (4) 4
diagnosis (4) 4
drug therapy (4) 4
leukemia, myeloid, acute - diagnosis (4) 4
leukemia, myeloid, acute - drug therapy (4) 4
medical colleges (4) 4
medicine & public health (4) 4
patients (4) 4
survival analysis (4) 4
young adult (4) 4
acute leukemia (3) 3
aml (3) 3
analysis (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic agents - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
azacitidine - analogs & derivatives (3) 3
biopsy (3) 3
bone marrow (3) 3
bone-marrow (3) 3
care and treatment (3) 3
chronic myelomonocytic leukemia (3) 3
clinical trials as topic (3) 3
conventional care regimens (3) 3
disease-free survival (3) 3
epidemiology (3) 3
follow-up studies (3) 3
health aspects (3) 3
kaplan-meier estimate (3) 3
leukemia, myeloid, acute - mortality (3) 3
mortality (3) 3
mutation (3) 3
myelodysplastic syndromes - mortality (3) 3
myeloid neoplasia (3) 3
outcomes (3) 3
pharmacology & pharmacy (3) 3
polycythemia-vera (3) 3
population studies (3) 3
rituximab (3) 3
surveillance (3) 3
survival rate (3) 3
transplantation (3) 3
tumors (3) 3
united-states (3) 3
5-aza-2'-deoxycytidine (2) 2
acute disease (2) 2
acute myelogenous leukemia (2) 2
acute myeloid leukemia (2) 2
adolescent (2) 2
adults (2) 2
age factors (2) 2
aged patients (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
calreticulin - genetics (2) 2
cancer research (2) 2
cancer therapies (2) 2
carcinoma (2) 2
care (2) 2
cetuximab (2) 2
clinical trial (2) 2
clonal hematopoiesis (2) 2
combined modality therapy - adverse effects (2) 2
combined modality therapy - methods (2) 2
confidence intervals (2) 2
cytarabine (2) 2
cytarabine - administration & dosage (2) 2
disease (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Hematology, ISSN 0939-5555, 10/2019, Volume 98, Issue 10, pp. 2421 - 2423
Journal Article
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 07/2019, Volume 20, Issue 10, pp. 1169 - 1173
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 06/2019, pp. 1 - 7
Most patients with lower risk myelodysplastic syndromes (LR-MDS) become red blood cell (RBC) transfusion dependent at some time during their disease course.... 
Journal Article
Journal of the National Comprehensive Cancer Network : JNCCN, ISSN 1540-1405, 03/2019, Volume 17, Issue 3, pp. 211 - 219
Background: Current guidelines recommend hydroxyurea (HU) as frontline therapy for patients with high-risk essential thrombocy-themia (ET) to prevent... 
ARTERIAL | MYELOPROLIFERATIVE NEOPLASMS | POLYCYTHEMIA-VERA | ONCOLOGY | ANAGRELIDE
Journal Article
American Journal of Clinical Pathology, ISSN 0002-9173, 02/2015, Volume 143, Issue 2, p. 308
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 10/2013, Volume 11, Issue 10, pp. 676 - 677
Journal Article
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 10/2013, Volume 11, Issue 10, pp. 675 - 677
Journal Article
Cancer, ISSN 0008-543X, 10/2017, Volume 123, Issue 19, pp. 3754 - 3762
Journal Article
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1317 - 1326
Journal Article
Cancer, ISSN 0008-543X, 11/2018, Volume 124, Issue 21, pp. 4211 - 4220
Whether provider‐level volume is associated with outcomes in cancers treated primarily with systemic therapy is unknown. Using a population‐based cohort study,... 
non‐Hodgkin lymphoma | volume–outcome | cancer outcomes | diffuse large B cell lymphoma | quality of care | non-Hodgkin lymphoma | SURVIVAL | INTENSITY | CANCER | CHEMOTHERAPY | IMPACT | OPERATIVE MORTALITY | HOSPITAL VOLUME | ONCOLOGY | RITUXIMAB | volume-outcome | SURGEON CHARACTERISTICS | ELDERLY-PATIENTS | Index Medicus | Abridged Index Medicus
Journal Article
Annals of Hematology, ISSN 0939-5555, 12/2018, Volume 97, Issue 12, pp. 2333 - 2343
Journal Article
British Journal of Haematology, ISSN 0007-1048, 12/2016, Volume 175, Issue 5, pp. 829 - 840
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.